About
This application allows University of Kentucky pharmacogenomics study participants to securely access and review their clinical reports and potential adverse medication effects based on their genomic profile. Users can conveniently discuss this information with their doctor at their leisure.
What's New in UK Multi23
1.2.0
November 4, 2022
Added an introduction video to explains more about the data provided in the application. This video will play when the application is first launched and is accessible via a button on the main menu for later review.
MoreDeveloper apps
FAQ
What can I do with UK Multi23?
UK Multi23 allows you to securely review your clinical report and any adverse medication effects related to your genomic profile. You can also use this information to discuss your results with your doctor.
Is UK Multi23 free to use?
Yes, UK Multi23 is completely free to download and use. There are no in-app purchases or subscription fees associated with accessing its features.
What devices support UK Multi23?
UK Multi23 is available on iPhone, iPad, and iPod devices. It is designed to provide a seamless experience across Apple's mobile ecosystem.
How often is UK Multi23 updated?
The latest version of UK Multi23 is 1.2.0, which was last updated on November 4, 2022. Updates typically focus on improving security and user experience.
What is the age rating for UK Multi23?
UK Multi23 has an age rating of 4+, making it suitable for a wide range of users. This rating indicates general appropriateness for most individuals.
Who developed UK Multi23?
UK Multi23 was developed by the University of Kentucky. This ensures that the app is built with the specific needs of their study participants in mind.
Does UK Multi23 have ads?
No, UK Multi23 does not contain advertisements. The app is designed to provide a focused and uninterrupted experience for reviewing sensitive health information.
What is the user feedback on UK Multi23?
UK Multi23 has received a perfect rating of 5.0 stars from one review. This suggests a highly positive initial user experience.
